[go: up one dir, main page]

ES2160712T3 - Nueva preparacion farmaceutica para tratamiento del dolor. - Google Patents

Nueva preparacion farmaceutica para tratamiento del dolor.

Info

Publication number
ES2160712T3
ES2160712T3 ES95926061T ES95926061T ES2160712T3 ES 2160712 T3 ES2160712 T3 ES 2160712T3 ES 95926061 T ES95926061 T ES 95926061T ES 95926061 T ES95926061 T ES 95926061T ES 2160712 T3 ES2160712 T3 ES 2160712T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
new pharmaceutical
pain treatment
pain
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95926061T
Other languages
English (en)
Inventor
Arne Brodin
Anders Carlsson
Bengt Herslof
Martin Nicklasson
Lisbeth Rydhag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2160712T3 publication Critical patent/ES2160712T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

NUEVA PREPARACION FARMACEUTICA QUE INCLUYE UNO O MAS AGENTES ANESTESICOS, UN LIPIDO POLAR, UN TRIACILGLICEROL Y OPCIONALMENTE AGUA. LA NUEVA PREPARACION FARMACEUTICA ES EXCELENTE PARA EL TRATAMIENTO TOPICO DEL DOLOR.
ES95926061T 1994-07-12 1995-06-21 Nueva preparacion farmaceutica para tratamiento del dolor. Expired - Lifetime ES2160712T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402453A SE9402453D0 (sv) 1994-07-12 1994-07-12 New pharmaceutical preparation

Publications (1)

Publication Number Publication Date
ES2160712T3 true ES2160712T3 (es) 2001-11-16

Family

ID=20394703

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95926061T Expired - Lifetime ES2160712T3 (es) 1994-07-12 1995-06-21 Nueva preparacion farmaceutica para tratamiento del dolor.

Country Status (30)

Country Link
US (1) US5912271A (es)
EP (1) EP0767669B1 (es)
JP (1) JPH10502631A (es)
KR (1) KR100399522B1 (es)
CN (1) CN1236759C (es)
AT (1) ATE202478T1 (es)
AU (1) AU686414B2 (es)
BR (1) BR9508373A (es)
CA (1) CA2193992A1 (es)
CZ (1) CZ379496A3 (es)
DE (1) DE69521512T2 (es)
DK (1) DK0767669T3 (es)
EE (1) EE9700008A (es)
ES (1) ES2160712T3 (es)
FI (1) FI970101A0 (es)
GR (1) GR3036745T3 (es)
HU (1) HUT76809A (es)
IL (1) IL114446A (es)
IS (1) IS4397A (es)
MX (1) MX9700272A (es)
NO (1) NO970067L (es)
NZ (1) NZ289954A (es)
PL (1) PL180504B1 (es)
PT (1) PT767669E (es)
SE (1) SE9402453D0 (es)
SK (1) SK281293B6 (es)
TR (1) TR199500847A2 (es)
TW (1) TW410159B (es)
WO (1) WO1996001637A1 (es)
ZA (1) ZA955327B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014946B1 (en) * 1997-09-18 2010-04-07 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
ES2384094T3 (es) 1997-11-14 2012-06-29 Pacira Pharmaceuticals, Inc. Producción de liposomas multivesiculares
SE9800729L (sv) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
SE515982C2 (sv) * 1998-03-06 2001-11-05 Lipocore Holding Ab Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IL140899A0 (en) 1998-07-17 2002-02-10 Skyepharma Inc Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
HK1040195B (zh) 1998-08-19 2006-06-02 Skyepharma Canada Inc. 普鲁泊福的可注射水分散体
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
DE60239528D1 (de) * 2001-05-01 2011-05-05 Corium International Redwood City Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
CA2445086C (en) 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20030027833A1 (en) * 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
WO2003020318A1 (en) * 2001-09-04 2003-03-13 Lipocore Holding Ab A topical w/o-emulsion composition
SE0102933D0 (sv) * 2001-09-04 2001-09-04 Lipocore Holding Ab Lipid carrier
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
AU2005271259B2 (en) * 2004-08-05 2012-01-19 A.V. Topchiev Institute Of Petrochemical Synthesis Adhesive composition
US8895084B2 (en) 2004-12-23 2014-11-25 Colgate-Palmolive Company Oral care composition containing extract of unoxidized Camellia
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CN101939010A (zh) * 2007-11-19 2011-01-05 雪印乳业株式会社 感觉改善剂
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
CN111840553A (zh) 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
GB2163956B (en) * 1984-09-08 1988-03-30 Ile De France Percutaneous anaesthetic composition for topical application
GB8712518D0 (en) * 1987-05-28 1987-07-01 Univ Belfast Unit-dose film composition
AU4216089A (en) * 1988-08-12 1990-03-05 Joel E. Bernstein Method and composition for treating and preventing dry skin disorders
FR2661331A1 (fr) * 1990-04-30 1991-10-31 Oreal Composition cosmetique ou dermopharmaceutique contenant des vesicules formees par un melange phospholipides/glycolipides.
JPH05163153A (ja) * 1991-12-19 1993-06-29 Q P Corp スフィンゴ脂質組成物
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
CA2137001C (en) * 1992-06-19 1999-05-04 Peter M. Elias Lipids for epidermal moisturization and repair of barrier function
FR2692781B1 (fr) * 1992-06-24 1995-05-05 Sederma Sa Nouvelles compositions cosmétiques contenant des sphingomyélines et autres lipides complexes.

Also Published As

Publication number Publication date
EP0767669B1 (en) 2001-06-27
SK281293B6 (sk) 2001-02-12
US5912271A (en) 1999-06-15
KR970704453A (ko) 1997-09-06
NZ289954A (en) 1997-12-19
IL114446A0 (en) 1995-11-27
EE9700008A (et) 1997-06-16
DE69521512D1 (de) 2001-08-02
ZA955327B (en) 1996-01-12
HU9700056D0 (en) 1997-02-28
FI970101L (fi) 1997-01-10
GR3036745T3 (en) 2001-12-31
CA2193992A1 (en) 1996-01-25
SK166196A3 (en) 1997-08-06
TR199500847A2 (tr) 1996-06-21
JPH10502631A (ja) 1998-03-10
CZ379496A3 (en) 1997-06-11
IL114446A (en) 1999-08-17
PL180504B1 (pl) 2001-02-28
HUT76809A (en) 1997-11-28
MX9700272A (es) 1997-05-31
PL318172A1 (en) 1997-05-26
AU2994395A (en) 1996-02-09
DE69521512T2 (de) 2001-10-25
ATE202478T1 (de) 2001-07-15
FI970101A7 (fi) 1997-01-10
IS4397A (is) 1996-12-17
NO970067D0 (no) 1997-01-08
BR9508373A (pt) 1997-10-28
SE9402453D0 (sv) 1994-07-12
NO970067L (no) 1997-01-08
KR100399522B1 (ko) 2004-02-18
WO1996001637A1 (en) 1996-01-25
DK0767669T3 (da) 2001-07-23
FI970101A0 (fi) 1997-01-10
EP0767669A1 (en) 1997-04-16
CN1236759C (zh) 2006-01-18
PT767669E (pt) 2001-10-30
CN1152873A (zh) 1997-06-25
TW410159B (en) 2000-11-01
AU686414B2 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
ES2160712T3 (es) Nueva preparacion farmaceutica para tratamiento del dolor.
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
ES2156150T3 (es) Combinacion terapeutica que contiene interferon.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
DK0607128T4 (da) Lægemiddel samt fremstilling deraf og anvendelse deraf ved bekæmpelsen af smerter og/eller betændelser hos dyr og mennesker
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE3382458D1 (de) Haarwuchsmittel.
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
DK0998287T3 (da) Anvendelse af levobupivacain
ES2181165T3 (es) Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2153519T3 (es) Anestesico local para la terapia topica de dolores de espalda y distension muscular.
ATE114244T1 (de) Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2152479T3 (es) Uso de preparaciones de inmunoglobulinas para la fabricacion de un medicamento de administracion oral para el tratamiento y la profilaxis de estados de dolor cronico.
ES2104142T3 (es) Aminociclohexilamidas para utilizacion antirritmica y anestesica.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
ES2191206T3 (es) Nueva utilizacion de la creatina.
ES2135065T3 (es) Derivados de amida y su uso terapeutico.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
SE8802040D0 (sv) New use
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
PT834316E (pt) Utilizacao da sulbutiamina para a obtencao de composicoes farmaceuticas uteis no tratamento de certas perturbacoes psicomotoras e psico-intelectuais
ATE74505T1 (de) Schmerzpraeparat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 767669

Country of ref document: ES